Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Cleton-Jansen

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Cancer Letters|November 19, 2015
Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signalingSara R Martins-Neves, Daniela I Paiva-Oliveira, Pauline M Wijers-Koster, et al.
BMC Cancer|July 16, 2016
No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneElisabeth F P Peterse, Arjen H G Cleven, Yvonne De Jong, et al.
Journal of the National Cancer Institute|March 8, 2007
The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletionsLiesbeth Hameetman, Karoly Szuhai, Ayse Yavas, et al.
Clinical Sarcoma Research|May 10, 2017
<i>IDH1</i> or -<i>2</i> mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomasArjen H G Cleven, Johnny Suijker, Georgios Agrogiannis, et al.
Cancer Research|December 17, 2005
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexRaman Kumar, Paul M Neilsen, Joanne Crawford, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 2017
Increased Risk of Breast Cancer at a Young Age in Women with Fibrous DysplasiaBas Cj Majoor, Alison M Boyce, Judith Vmg Bovée, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression dataMarieke L Kuijjer, Halfdan Rydbeck, Stine H Kresse, et al.
Oncotarget|September 30, 2015
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicinZuzanna Baranski, Yvonne de Jong, Trayana Ilkova, et al.
The Journal of Pathology|December 22, 2025
Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell-of-origin model for osteoid osteoma and osteoblastomaSuk Wai Lam, Tatiana Belova, Natasja Franceschini, et al.
Clinical Sarcoma Research|June 25, 2015
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term cultureEmilie P Buddingh, S Eriaty N Ruslan, Christianne M A Reijnders, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Cancer Letters|November 19, 2015
Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signalingSara R Martins-Neves, Daniela I Paiva-Oliveira, Pauline M Wijers-Koster, et al.
BMC Cancer|July 16, 2016
No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneElisabeth F P Peterse, Arjen H G Cleven, Yvonne De Jong, et al.
Journal of the National Cancer Institute|March 8, 2007
The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletionsLiesbeth Hameetman, Karoly Szuhai, Ayse Yavas, et al.
Clinical Sarcoma Research|May 10, 2017
<i>IDH1</i> or -<i>2</i> mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomasArjen H G Cleven, Johnny Suijker, Georgios Agrogiannis, et al.
Cancer Research|December 17, 2005
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexRaman Kumar, Paul M Neilsen, Joanne Crawford, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 2017
Increased Risk of Breast Cancer at a Young Age in Women with Fibrous DysplasiaBas Cj Majoor, Alison M Boyce, Judith Vmg Bovée, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression dataMarieke L Kuijjer, Halfdan Rydbeck, Stine H Kresse, et al.
Oncotarget|September 30, 2015
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicinZuzanna Baranski, Yvonne de Jong, Trayana Ilkova, et al.
The Journal of Pathology|December 22, 2025
Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell-of-origin model for osteoid osteoma and osteoblastomaSuk Wai Lam, Tatiana Belova, Natasja Franceschini, et al.
Clinical Sarcoma Research|June 25, 2015
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term cultureEmilie P Buddingh, S Eriaty N Ruslan, Christianne M A Reijnders, et al.
Pageof 13